FLT3 signaling in hematopoietic cells involves CBL, SHC and an unknown P115 as prominent tyrosine-phosphorylated substrates

Leukemia

Volumn 12, Issue 3, 1998, Pages 301-310

  Lavagna Sevenier C ^a   Marchetto, S ^a   Birnbaum, D ^a   Rosnet, O ^a  

^a INSERM   (France)

Author keywords

CBL; FLT3; Hematopoietic cells; SHC; Signal transduction; Tyrosine phosphorylation

Indexed keywords

LIGAND; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE;

ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; COMPLEX FORMATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0031883328     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400921     Document Type: Article

References (20)

1. Metcalf D. Hematopoietic regulators: redundancy or subtlety. Blood 1993; 82: 3515-3523.
2. D'Andrea A. Hematopoietic growth factors and the regulation of differentiative decisions. Curr Opin Cell Biol 1994; 6: 804-808.
3. Miyajima A, Kitamura T, Harada N, Yokota T, Arai K-I. Cytokine receptors and signal transduction. Annu Rev Immunol 1992; 10: 295-331.
4. Rosnet O, Birnbaum D. Hematopoietic receptors of class III receptor-type tyrosine kinases. Crit Rev Oncogenesis 1993; 4: 595-613.
5. Ihle J. Cytokine receptor signalling. Nature 1995; 377: 591-594.
6. Erpel T, Courtneidge S. Src family protein kinases and cellular signal transduction pathways. Curr Opin Cell Biol 1995; 7:176-182.
7. Lyman S, Williams D. Biology and potential clinical applications of flt3 ligand. Curr Opin Hematol 1995; 2: 177-181.
8. Pawson T. Tyrosine kinases and their interactions with signalling proteins. Curr Opin Cen Dev 1992; 2: 4-12.
9. Van Der Geer P, Hunter T. Receptor protein-tyrosine kinases and their signal transduction pathways. Ann Rev Cell Biol 1994; 10: 251-337.
10. Sun H, Tonks N. The coordinated action of protein tyrosine kinases in cell signaling. Trends Biochem Sci 1994; 19: 480-485.
11. Cohen G, Ren R, Baltimore D. Modular binding domains in signal transduction proteins. Cell 1995; 80: 237-248.
12. Chan D, Bedford M, Leder P. Formin binding proteins bear WW/WWP domains that bind proline-rich peptides and functionally resemble SH3 domains. EMBO J 1996; 15: 1045-1054.
13. Harrison S. Peptide-surface associations: the case of PDZ and PTB domains. Cell 1996; 86: 341-343.
14. Van Der Geer P, Pawson T. The PTB domain: a new protein module implicated in signal transduction. Trends Biochem Sci 1995; 20: 277-280.
15. Mackaretschian K, Hardin J, Moore K, Boast S, Goff S, Lemischka I. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 1995; 3: 147-161.
16. + cells in vitro. Nature Mod 1996; 2: 46-51.
17. Hannum C, Culpepper J, Campbell D, McClanahan T, Zurawski S, Bazan JF, Kastelein R, Hudak S, Wagner J, Mattson J, Luh J, Duda G, Martina M, Peterson D, Menton S, Shanafelt A, Muench M, Kelner G, Namikawa R, Rennick D, Roncarolo M-G, Zlotnik A, Rosnet O, Dubreuil P, Birnbaum D, Lee F. Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of hematopoietic stem cells and is encoded by variant RNAs. Nature 1994; 368: 643-648.
18. Gabbianelli M, Pelosi E, Montesoro E, Valtieri M, Luchetti M, Samoggia P, Vitelli L, Barberi T, Testa U, Lyman S, Peschle C. Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors. Blood1995; 86: 1661-1670.
19. Namikawa R, Muench M, de Vries J, Roncarolo M-C. The FLK2/FLT3 ligand synergizes with interleukin-7 in promoting stromal-cell-independent expansion and differentiation of human fetal pro-B cells in vitro. Blood 1996; 87: 1881-1890.
20. Veiby O, Lyman S, Jacobsen S. Combined signaling through interleukin-7 receptors and flt3 but not c-kit potently and selectively promotes B-cell commitment and differentiation from uncommited murine bone marrow progenitor cells. Blood 1996; 88: 1256-1265.